This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ho Jin Han - Innovator in Anticancer Pharmaceutical Composition
Introduction
Ho Jin Han is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticancer properties. His work focuses on creating effective treatments with minimal side effects.
Latest Patents
Ho Jin Han holds a patent for a benzofuran-based N-acylhydrazone derivative. This innovative compound demonstrates an excellent anticancer effect while maintaining low toxicity and high solubility. The pharmaceutical composition comprising this derivative is particularly useful for preventing or treating cell proliferative disorders, including various types of cancer.
Career Highlights
Han is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts research aimed at advancing medical treatments. His dedication to improving cancer therapies has positioned him as a key figure in the pharmaceutical research community.
Collaborations
Some of his notable coworkers include Nak Kyun Soung and In Ja Ryoo, who contribute to the collaborative efforts in research and development within their institution.
Conclusion
Ho Jin Han's innovative work in developing anticancer pharmaceutical compositions highlights his commitment to advancing medical science. His contributions are paving the way for more effective cancer treatments with reduced side effects.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
